Tempus AI is trading 4.09% up at $66.42, with the gain accompanying its October 23 announcement of agreements with Bristol Myers Squibb and Pathos AI.
- The agreements provide up to $192.5 million in cash payments over approximately five years for expanded data, software, and AI model access.
- The broader market was mixed at midday: the Nasdaq was slightly positive, while the S&P 500 and Dow were lower.